{"id":2057,"date":"2023-08-17T17:57:14","date_gmt":"2023-08-17T15:57:14","guid":{"rendered":"https:\/\/neurocirugialmeria.com\/?p=2057"},"modified":"2023-08-17T17:57:14","modified_gmt":"2023-08-17T15:57:14","slug":"lecanemab-esperanza-frente-al-alzheimer-precoz","status":"publish","type":"post","link":"https:\/\/neurocirugialmeria.com\/en\/2023\/08\/17\/lecanemab-esperanza-frente-al-alzheimer-precoz\/","title":{"rendered":"Lecanemab: \u00bfEsperanza frente al  Alzheimer precoz?"},"content":{"rendered":"<p class=\"has-text-align-center wp-block-paragraph\">Los resultados de un ensayo cl\u00ednico en fase III han sido publicados en la revista <a href=\"https:\/\/www.nejm.org\/\">New England Journal of Medicine<\/a>. En dicho ensayo se prob\u00f3 la efectividad del Lecanemab, un anticuerpo monoclonal contra la prote\u00edna amiloide para tratar de reducir el dep\u00f3sito de la misma en el cerebro.<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">Con un dise\u00f1o triple ciego fueron incluidos un total de 1795 pacientes en el trabajo asignados a un grupo tratamiento y a un grupo placebo. La evaluaci\u00f3n de resultados se bas\u00f3 fundamentalmente en las variaciones apreciadas durante 18 meses en la escala de demencias CDR as\u00ed como en los marcadores de enfermedad de Alzheimer en la neuroimagen.<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">Se observ\u00f3 de forma muy sutil un retraso en la evoluci\u00f3n de la enfermedad medido por la escala CDR. Por otro lado, se apreci\u00f3 de forma m\u00e1s evidente un menor dep\u00f3sito de amiloide en los pacientes que recibieron Lecanemab.  <\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">Se registr\u00f3 una mayor frecuencia de efectos adversos derivados de la infusi\u00f3n del f\u00e1rmaco frente a lo observado en el gruipo placebo. Ser\u00e1n necesarios nuevos ensayos para determinar el posible papel de este f\u00e1rmaco para detener la enfermedad de Alzheimer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fuente:<\/strong> <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2212948\">van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. Lecanemab in Early Alzheimer&#8217;s Disease. N Engl J Med. 2023 Jan 5;388(1):9-21.<\/a>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Los resultados de un ensayo cl\u00ednico en fase III han sido publicados en la revista New England Journal of Medicine. En dicho ensayo se prob\u00f3 la efectividad del Lecanemab, un anticuerpo monoclonal contra la prote\u00edna amiloide para tratar de reducir el dep\u00f3sito de la misma en el cerebro. Con un dise\u00f1o triple ciego fueron incluidos&#8230;<\/p>","protected":false},"author":183523340,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_seo_schema_type":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_wpcom_ai_launchpad_first_post":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"{title}\n\n{excerpt}\n\n{url}","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false,"jetpack_post_was_ever_published":false},"categories":[1771],"tags":[],"class_list":["post-2057","post","type-post","status-publish","format-standard","hentry","category-sin-categoria"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pbS7CP-xb","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/posts\/2057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/users\/183523340"}],"replies":[{"embeddable":true,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/comments?post=2057"}],"version-history":[{"count":2,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/posts\/2057\/revisions"}],"predecessor-version":[{"id":2060,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/posts\/2057\/revisions\/2060"}],"wp:attachment":[{"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/media?parent=2057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/categories?post=2057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/tags?post=2057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}